Synopsis
0
JDMF
0
KDMF
0
VMF
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Date of Issue : 2022-05-02
Valid Till : 2025-05-01
Written Confirmation Number : WC-0526
Address of the Firm : Plot No-30, Jawaharlal Nehru Pharamacity, Parawada (M), Vishakapatnam 531019 Dis...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-09-30
Valid Till : 2025-11-30
Written Confirmation Number : WC-390A4
Address of the Firm : CTO-SEZ Process Unit -01,\\\\r\\\\nSector No 28 to 34, 36 to 37, 40, 50 to 53 & ...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm : CTO-SEZ-Process Unit-01, Sector No 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
About the Company : Granules is a fast-growing, vertically integrated pharmaceutical company headquartered in Hyderabad, committed to operational excellence, quality, and customer service. It manufact...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Emay Pharmaceuticals is a GMP-certified API manufacturing company.
About the Company : Emay Pharmaceuticals Pvt Ltd functions as the merchant export division of M/s. Bhavna Laboratories Pvt Ltd. As a GMP-approved API manufacturing company, we boast over three decades...
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 1...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
USFDA APPLICATION NUMBER - 19962
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 2...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
USFDA APPLICATION NUMBER - 19962
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 2...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
USFDA APPLICATION NUMBER - 19962
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
USFDA APPLICATION NUMBER - 19962
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG TARTRATE
USFDA APPLICATION NUMBER - 210428
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 200MG TARTRATE
USFDA APPLICATION NUMBER - 210428
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 25MG TARTRATE
USFDA APPLICATION NUMBER - 210428
DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ ...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 50MG TARTRATE
USFDA APPLICATION NUMBER - 210428
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21956
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21956
DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 21956
Related Excipient Companies
Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Chynops Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pramukh Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zeal MediPharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NEWEDGE Overseas
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Thickeners and Stabilizers
Solubilizers
Disintegrants & Superdisintegrants
Direct Compression
Granulation
Lubricants & Glidants
Film Formers & Plasticizers
Topical
Taste Masking
Co-Processed Excipients
Parenteral
Chewable & Orodispersible Aids
Rheology Modifiers
Empty Capsules
Emulsifying Agents
API Stability Enhancers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
80
PharmaCompass offers a list of Metoprolol Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metoprolol Succinate manufacturer or Metoprolol Succinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metoprolol Succinate manufacturer or Metoprolol Succinate supplier.
PharmaCompass also assists you with knowing the Metoprolol Succinate API Price utilized in the formulation of products. Metoprolol Succinate API Price is not always fixed or binding as the Metoprolol Succinate Price is obtained through a variety of data sources. The Metoprolol Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metoprolol succinate extended-release tablets manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metoprolol succinate extended-release tablets, including repackagers and relabelers. The FDA regulates Metoprolol succinate extended-release tablets manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metoprolol succinate extended-release tablets API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metoprolol succinate extended-release tablets manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metoprolol succinate extended-release tablets supplier is an individual or a company that provides Metoprolol succinate extended-release tablets active pharmaceutical ingredient (API) or Metoprolol succinate extended-release tablets finished formulations upon request. The Metoprolol succinate extended-release tablets suppliers may include Metoprolol succinate extended-release tablets API manufacturers, exporters, distributors and traders.
click here to find a list of Metoprolol succinate extended-release tablets suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metoprolol succinate extended-release tablets DMF (Drug Master File) is a document detailing the whole manufacturing process of Metoprolol succinate extended-release tablets active pharmaceutical ingredient (API) in detail. Different forms of Metoprolol succinate extended-release tablets DMFs exist exist since differing nations have different regulations, such as Metoprolol succinate extended-release tablets USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metoprolol succinate extended-release tablets DMF submitted to regulatory agencies in the US is known as a USDMF. Metoprolol succinate extended-release tablets USDMF includes data on Metoprolol succinate extended-release tablets's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metoprolol succinate extended-release tablets USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metoprolol succinate extended-release tablets suppliers with USDMF on PharmaCompass.
A Metoprolol succinate extended-release tablets CEP of the European Pharmacopoeia monograph is often referred to as a Metoprolol succinate extended-release tablets Certificate of Suitability (COS). The purpose of a Metoprolol succinate extended-release tablets CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metoprolol succinate extended-release tablets EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metoprolol succinate extended-release tablets to their clients by showing that a Metoprolol succinate extended-release tablets CEP has been issued for it. The manufacturer submits a Metoprolol succinate extended-release tablets CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metoprolol succinate extended-release tablets CEP holder for the record. Additionally, the data presented in the Metoprolol succinate extended-release tablets CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metoprolol succinate extended-release tablets DMF.
A Metoprolol succinate extended-release tablets CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metoprolol succinate extended-release tablets CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metoprolol succinate extended-release tablets suppliers with CEP (COS) on PharmaCompass.
A Metoprolol succinate extended-release tablets written confirmation (Metoprolol succinate extended-release tablets WC) is an official document issued by a regulatory agency to a Metoprolol succinate extended-release tablets manufacturer, verifying that the manufacturing facility of a Metoprolol succinate extended-release tablets active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metoprolol succinate extended-release tablets APIs or Metoprolol succinate extended-release tablets finished pharmaceutical products to another nation, regulatory agencies frequently require a Metoprolol succinate extended-release tablets WC (written confirmation) as part of the regulatory process.
click here to find a list of Metoprolol succinate extended-release tablets suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metoprolol succinate extended-release tablets as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metoprolol succinate extended-release tablets API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metoprolol succinate extended-release tablets as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metoprolol succinate extended-release tablets and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metoprolol succinate extended-release tablets NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metoprolol succinate extended-release tablets suppliers with NDC on PharmaCompass.
Metoprolol succinate extended-release tablets Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metoprolol succinate extended-release tablets GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metoprolol succinate extended-release tablets GMP manufacturer or Metoprolol succinate extended-release tablets GMP API supplier for your needs.
A Metoprolol succinate extended-release tablets CoA (Certificate of Analysis) is a formal document that attests to Metoprolol succinate extended-release tablets's compliance with Metoprolol succinate extended-release tablets specifications and serves as a tool for batch-level quality control.
Metoprolol succinate extended-release tablets CoA mostly includes findings from lab analyses of a specific batch. For each Metoprolol succinate extended-release tablets CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metoprolol succinate extended-release tablets may be tested according to a variety of international standards, such as European Pharmacopoeia (Metoprolol succinate extended-release tablets EP), Metoprolol succinate extended-release tablets JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metoprolol succinate extended-release tablets USP).
